Literature DB >> 28833307

A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.

Joseph Antonelli1, Bing Han2, Matthew Cefalu2.   

Abstract

A critical issue in the analysis of clinical trials is patients' noncompliance to assigned treatments. In the context of a binary treatment with all or nothing compliance, the intent-to-treat analysis is a straightforward approach to estimating the effectiveness of the trial. In contrast, there exist 3 commonly used estimators with varying statistical properties for the efficacy of the trial, formally known as the complier-average causal effect. The instrumental variable estimator may be unbiased but can be extremely variable in many settings. The as treated and per protocol estimators are usually more efficient than the instrumental variable estimator, but they may suffer from selection bias. We propose a synthetic approach that incorporates all 3 estimators in a data-driven manner. The synthetic estimator is a linear convex combination of the instrumental variable, per protocol, and as treated estimators, resembling the popular model-averaging approach in the statistical literature. However, our synthetic approach is nonparametric; thus, it is applicable to a variety of outcome types without specific distributional assumptions. We also discuss the construction of the synthetic estimator using an analytic form derived from a simple normal mixture distribution. We apply the synthetic approach to a clinical trial for post-traumatic stress disorder.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  causal inference; clinical trials; model averaging; noncompliance; principle stratification

Mesh:

Year:  2017        PMID: 28833307      PMCID: PMC5698094          DOI: 10.1002/sim.7447

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

Review 1.  What is meant by intention to treat analysis? Survey of published randomised controlled trials.

Authors:  S Hollis; F Campbell
Journal:  BMJ       Date:  1999-09-11

2.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

3.  Uses and limitations of randomization-based efficacy estimators.

Authors:  Ian R White
Journal:  Stat Methods Med Res       Date:  2005-08       Impact factor: 3.021

4.  Variable selection for logistic regression using a prediction-focused information criterion.

Authors:  Gerda Claeskens; Christophe Croux; Johan Van Kerckhoven
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

5.  Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.

Authors:  Peter Roy-Byrne; Michelle G Craske; Greer Sullivan; Raphael D Rose; Mark J Edlund; Ariel J Lang; Alexander Bystritsky; Stacy Shaw Welch; Denise A Chavira; Daniela Golinelli; Laura Campbell-Sills; Cathy D Sherbourne; Murray B Stein
Journal:  JAMA       Date:  2010-05-19       Impact factor: 56.272

Review 6.  Compliance in clinical trials.

Authors:  C L Besch
Journal:  AIDS       Date:  1995-01       Impact factor: 4.177

7.  Impact of Collaborative Care for Underserved Patients with PTSD in Primary Care: a Randomized Controlled Trial.

Authors:  Lisa S Meredith; David P Eisenman; Bing Han; Bonnie L Green; Stacey Kaltman; Eunice C Wong; Melony Sorbero; Christine Vaughan; Andrea Cassells; Douglas Zatzick; Claudia Diaz; Scot Hickey; Jeremy R Kurz; Jonathan N Tobin
Journal:  J Gen Intern Med       Date:  2016-02-05       Impact factor: 5.128

8.  Design of the Violence and Stress Assessment (ViStA) study: a randomized controlled trial of care management for PTSD among predominantly Latino patients in safety net health centers.

Authors:  Lisa S Meredith; David P Eisenman; Bonnie L Green; Stacey Kaltman; Eunice C Wong; Bing Han; Andrea Cassells; Jonathan N Tobin
Journal:  Contemp Clin Trials       Date:  2014-04-18       Impact factor: 2.226

9.  A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance.

Authors:  Roderick J Little; Qi Long; Xihong Lin
Journal:  Biometrics       Date:  2008-05-28       Impact factor: 2.571

10.  RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial.

Authors:  Paula P Schnurr; Matthew J Friedman; Thomas E Oxman; Allen J Dietrich; Mark W Smith; Brian Shiner; Elizabeth Forshay; Jiang Gui; Veronica Thurston
Journal:  J Gen Intern Med       Date:  2012-08-03       Impact factor: 5.128

View more
  1 in total

1.  Providing Health Physicals and/or Health Monitoring Services in Mental Health Clinics: Impact on Laboratory Screening and Monitoring for High Risk Populations.

Authors:  Joshua Breslau; Emily Leckman-Westin; Bing Han; Diana Guarasi; Hao Yu; Marcela Horvitz-Lennon; Riti Pritam; Molly Finnerty
Journal:  Adm Policy Ment Health       Date:  2021-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.